IGFALS
Basic information
Region (hg38): 16:1790413-1794971
Links
Phenotypes
GenCC
Source:
- short stature due to primary acid-labile subunit deficiency (Strong), mode of inheritance: AR
- short stature due to primary acid-labile subunit deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Insulin-like growth factor-binding protein, acid-labile subunit, deficiency of | AR | Endocrine | As growth hormone treatment has not been reported as being effective in this condition, genetic diagnosis may be beneficial in terms of pursuing optimal management | Endocrine | 14762184; 17726072; 21396577; 21664162; 23488611 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGFALS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 13 | 34 | |||
missense | 92 | 104 | ||||
nonsense | 3 | |||||
start loss | 1 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 10 | 15 | ||||
Total | 1 | 4 | 116 | 24 | 15 |
Highest pathogenic variant AF is 0.0000263
Variants in IGFALS
This is a list of pathogenic ClinVar variants found in the IGFALS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1790425-G-A | Short stature due to primary acid-labile subunit deficiency | Likely benign (Jan 13, 2018) | ||
16-1790445-A-C | Short stature due to primary acid-labile subunit deficiency | Likely benign (Jan 13, 2018) | ||
16-1790460-G-A | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 12, 2018) | ||
16-1790498-G-C | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790517-C-T | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790527-A-G | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790550-A-G | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 12, 2018) | ||
16-1790565-G-C | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790577-G-A | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790600-T-A | Uncertain significance (Apr 18, 2024) | |||
16-1790623-C-T | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790631-T-C | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Apr 27, 2017) | ||
16-1790635-G-A | not specified | Uncertain significance (Feb 15, 2024) | ||
16-1790639-G-C | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790641-C-T | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Oct 12, 2017) | ||
16-1790646-C-T | Uncertain significance (May 01, 2019) | |||
16-1790656-C-T | Inborn genetic diseases | Uncertain significance (Mar 22, 2022) | ||
16-1790694-G-A | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790700-G-A | Inborn genetic diseases | Uncertain significance (Oct 12, 2022) | ||
16-1790710-C-T | Short stature due to primary acid-labile subunit deficiency • not specified | Uncertain significance (Feb 22, 2024) | ||
16-1790721-C-T | Short stature due to primary acid-labile subunit deficiency • Inborn genetic diseases | Uncertain significance (Sep 16, 2021) | ||
16-1790723-G-C | Inborn genetic diseases | Uncertain significance (Apr 20, 2024) | ||
16-1790724-A-G | Short stature due to primary acid-labile subunit deficiency | Uncertain significance (Jan 13, 2018) | ||
16-1790740-G-A | not specified | Uncertain significance (Dec 01, 2023) | ||
16-1790767-C-T | Short stature due to primary acid-labile subunit deficiency • Inborn genetic diseases | Uncertain significance (Apr 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IGFALS | protein_coding | protein_coding | ENST00000415638 | 2 | 4559 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.44e-11 | 0.0170 | 125160 | 0 | 53 | 125213 | 0.000212 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.22 | 479 | 409 | 1.17 | 0.0000327 | 3959 |
Missense in Polyphen | 152 | 131.51 | 1.1558 | 1508 | ||
Synonymous | -2.15 | 252 | 212 | 1.19 | 0.0000171 | 1456 |
Loss of Function | -0.843 | 14 | 11.0 | 1.27 | 5.67e-7 | 115 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000473 | 0.000473 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000167 | 0.000163 |
Finnish | 0.000188 | 0.000139 |
European (Non-Finnish) | 0.000153 | 0.000142 |
Middle Eastern | 0.000167 | 0.000163 |
South Asian | 0.000395 | 0.000392 |
Other | 0.000525 | 0.000491 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in protein-protein interactions that result in protein complexes, receptor-ligand binding or cell adhesion.;
- Pathway
- Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.442
Intolerance Scores
- loftool
- 0.542
- rvis_EVS
- -0.88
- rvis_percentile_EVS
- 10.5
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- N
- hipred_score
- 0.306
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.704
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Igfals
- Phenotype
- reproductive system phenotype; skeleton phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- cell adhesion;signal transduction;cellular protein metabolic process
- Cellular component
- extracellular region;extracellular space;nucleoplasm;extracellular matrix;insulin-like growth factor ternary complex;extracellular exosome
- Molecular function
- insulin-like growth factor binding